Replimune (REPL) Assets Average (2018 - 2025)

Replimune's (REPL) quarterly Assets Average came in at $361.5 million in Q4 2025, down 34.38% year-on-year from $550.9 million in Q4 2024, and down 15.82% quarter-over-quarter from $429.5 million in Q3 2025.

Replimune (REPL) Assets Average (2018 - 2025) Analysis & Trends

Replimune has disclosed Assets Average across 8 years of filings, most recently posting $361.5 million for Q4 2025.

  • Assets Average for Q4 2025 came in at $361.5 million, down 34.38% year-over-year; the trailing twelve-month figure through Dec 2025 was $361.5 million (down 34.38% YoY), and the FY2025 annual result was $519.5 million, down 8.4% from the prior year.
  • Assets Average came in at $361.5 million for Q4 2025 at Replimune, down from $429.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $662.6 million in Q1 2023 to a low of $361.5 million in Q4 2025.
  • The 5-year median for Assets Average is $515.1 million (2021), against an average of $520.9 million.
  • Across the five-year window, Assets Average jumped 127.5% in 2021 and tumbled 34.38% in 2025, its largest moves.
  • Replimune's Assets Average stood at $494.4 million in 2021, then increased by 12.73% to $557.3 million in 2022, then decreased by 1.73% to $547.7 million in 2023, then increased by 0.59% to $550.9 million in 2024, then sank by 34.38% to $361.5 million in 2025.
  • The last three Assets Average figures came in at $361.5 million (Q4 2025), $429.5 million (Q3 2025), and $510.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 33.42 Mn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 795.91 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 13.04 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 1.72 Bn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 40.89 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 26.03 Mn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 10.06 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 26.06 Bn
9 Abivax 91.71 Bn 91.71 Bn - 660.38 Mn
10 Replimune 780.01 Mn 510.88 Mn - 361.52 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 361.52 Mn
Sep 30, 2025 429.48 Mn
Jun 30, 2025 510.42 Mn
Mar 31, 2025 577.48 Mn
Dec 31, 2024 550.92 Mn
Sep 30, 2024 516.58 Mn
Jun 30, 2024 511.34 Mn
Mar 31, 2024 510.33 Mn
Dec 31, 2023 547.66 Mn
Sep 30, 2023 583.14 Mn
Jun 30, 2023 625.24 Mn
Mar 31, 2023 662.57 Mn
Dec 31, 2022 557.32 Mn
Sep 30, 2022 447.76 Mn
Jun 30, 2022 460.31 Mn
Mar 31, 2022 473.24 Mn
Dec 31, 2021 494.37 Mn
Sep 30, 2021 513.59 Mn
Jun 30, 2021 533.41 Mn
Mar 31, 2021 551.15 Mn